Eastern Food Allergy & Comorbidity Conference 2025 (EFACC)
The 2025 EFACC activity will provide conference attendees with knowledge regarding novel food allergy developments and the expanding therapeutic armamentarium in the field of allergy, asthma and immunology, particularly as it relates to food allergies and associated allergic comorbidities. In addition to a didactic review of relevant guidelines and recent clinical studies, the format will incorporate problem-based learning (PBL), uniquely designed to interface with lectures in context to the core learning objectives relevant to the cases. By means of active discussion, learners will be challenged to formulate and justify medical decision-making concerning diagnostic and treatment strategies for patients food allergy and comorbid allergic diseases. Topics of discussion will include food allergy prevention, food allergy immunotherapy, asthma, atopic dermatitis, eosinophilic esophagitis and shared decision making.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Eastern Food Allergy & Comorbidity Conference (EFACC) The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 16.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 16.25 contact hours.
Commercial Support
No commercial support was received for this activity.
Target Audience
Practicing allergists
Primary care physicians
Allied healthcare professionals
Learning Objectives
At the conclusion of this Activity learners should be able to…
1. Initiate an appropriate treatment strategy for eosinophilic esophagitis.
2. Discuss the risks and benefits of various forms of food immunotherapy.
3. Manage intermittent, mild/moderate, and severe persistent asthma as comorbidities of food allergy.
4. Manage atopic dermatitis as a comorbidity of food allergy.
5. Incorporate shared decision-making into food allergy management.
6. Optimize anaphylaxis preparedness and treatment in food allergy.
Eastern Food Allergy & Comorbidity Conference Meeting Program
January 9 -12, 2025
The Breakers, Palm Beach FL
Thursday, January 9, 2025
Moderator: Katherine Anagnostou, MD
3:30-4:00 Food allergy has come a long way: Where should it go from here? – Sami Bahna, MD
4:00-4:30 Management options for EoE: Use of biologics – Peter Capucilli, MD
4:30-5:00 Atopic dermatitis management: Key messages from the new practice parameter update – Peck Ong, MD
5:00-5:15 Panel Discussion: Q & A
5:15-5:45 Journal of Food Allergy: Year-in-review workshop – Katherine Anagnostou, MD
5:45-6:15 How do food allergies and immune deficiencies interact? – Joseph Bellanti, MD
6:15-6:30 Panel Discussion: Q & A
Adjourn
Friday, January 10, 2025
Moderator: Katherine Anagnostou, MD
7:45-8:15 Managing food allergy in 2025: An evolving landscape – Rima Rachid, MD
8:15-9:30 PBL: A five-year-old with milk, egg and peanut allergy, SAR and intermittent asthma
Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD, Dana Wallace, MD
9:30-10:15 Coffee Break: Visit exhibits and posters
10:15-10:45 Oral immunotherapy in food allergy – Anna Nowak-Wegrzyn, MD
10:45-11:15 Omalizumab for food allergy: Risks and benefits – Shahzad Mustafa, MD
11:15-11:45 Sublingual immunotherapy for food allergy: How and when to use – Edwin Kim, MD
11:45-12:15 Epicutaneous immunotherapy for peanut allergy: An update – Matthew Greenhawt, MD
12:15-12:30 Panel Discussion: Q & A
Moderator: Robert Settipane, MD
1:25-2:50 Workshops
Shared decision-making in food allergy therapies
Matthew Greenhawt, MD and Katherine Anagnostou, MD
Communicating new therapies to patients and providing reliable resources
Julie Wang, MD and Doug Mack, MD
2:50-3:00 Panel Discussion: Q & A
Adjourn
Saturday, January 11, 2025
Moderator: Russell Settipane, MD
7:45-8:15 Anaphylaxis Practice Parameter: Key messages – Jay Lieberman, MD
8:15-9:30 PBL: A 15-year-old with asthma tree nut allergy experiencing multiple episodes of anaphylaxis
Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD Marcus Shaker, MD
9:30-10:15 Coffee Break: Visit exhibits and posters
10:15-10:45 Anaphylaxis Update 1: When to activate EMS – Marcus Shaker, MD
10:45-11:15 Anaphylaxis update 2: Epinephrine devices for food-allergic individuals: Who, how many and when to use – Jay Lieberman, MD
11:15-11:45 Anaphylaxis update 3: How to prepare schools and the community to manage anaphylaxis – Julie Wang, MD
11:45-12:15 How to manage asthma in a food-allergic patient: A practical approach – Doug Mack, MD
12:15-12:30 Panel Discussion: Q & A
Moderator: William Corrao, MD
1:25-1: 55 Yellow zone management for intermittent and mild/moderate persistent asthma – Shahzad Mustafa, MD
1:55-2:20 Biologics in asthma management – Rima Rachid, MD
2:20-2:50 The use of thresholds in food allergy management – Marcus Shaker, MD
2:50-3:00 Panel Discussion: Q & A
Adjourn
Sunday, January 12, 2025
Moderator: William Greisner, MD
8:15-8:45 Management options for EoE: Diet or steroids? – Emily McGowan, MD
8:45-9:15 Challenging cases in FPIES management – Anna Nowak-Wegrzyn, MD
9:15-9:45 Selecting patients for food allergy therapy – Katherine Anagnostou, MD
9:45-10:15 Workshop: Preparing food allergic patients for college: Practical advice and resources – Ruchi Gupta, MD
10:15 -10:30 Panel Discussion: Q & A
Adjourn
All identified relevant financial relationships with ineligible companies have been mitigated.
Katherine Anagnostou, MD – Speaker, Planner, Moderator
Advisor: Novartis, Genentech, ARS, Bryn
Speaker: Genentech, ARS
Researcher: Novartis
Don Bukstein, MD - Speaker
Speaker: Regeneron
Advisor: Amphaster
Ray Davis, MD - Speaker
Consultant: Sanofi, Regeneron, Grifols, Kalvista, AstraZeneca
Matthew Greenhawt, MD - Speaker
Speaker: Genentech
Consultant: Aquestive
Advisor: Nutricia, DBV, Novartis, Aquestive, Prota, Allergy Therapeutics, ALK-Abello, AstraZeneca, Bryn, Genentech, Takeda, Grifols
William Greisner, III, MD – Planner, Moderator
Researcher: Allakos, AstraZeneca, GSK, Eli Lilly
Ruchi Gupta, MD - Speaker
Researcher: Novartis, Genentech
Consultant: Novartis, Genentech, OWYN, Kaleo, Aquestive Therapeutics, Bryn Pharma
Edwin Kim MD - Speaker
Advisor: ALK, Cellergy Pharm, Ukko
Consultant: Genentech, Hanimune Therapeutics, Novartis, Phylaxis Bioscience, Revolo Biotherapeutics, Allakos, DBV Technologies
Jay Lieberman, MD - Speaker
Advisor: AbbVie, Aquestive, ARS, Bryn, Celldex, Genentech, Novartis, Theravia
Consultant: AbbVie, Novartis, Aquestive, ARS, Bryn, Celldex, Genentech, Novartis, Theravia
Researcher: DBV
Doug Mack, MD - Speaker
Researcher: ALK-Abello, DBV, AstraZeneca, Arcutis, Dermavant, Sanofi, Leo
Advisor: DBV, Bausch Health, ALK Abello, Covis, Trudell, GSK
Speaker: DBV, ALK-Abello, Bausch Health, Covis, Trudell, GSK
S. Shahzad Mustafa, MD – Speaker
Speaker: Genentech, Regeneron/Sanofi, GSK, AstraZeneca, CSL Behring
Anna Nowak-Wegrzyn, MD - Speaker
Speaker: Nestle Sciences, Danone Nutricia, Thermofisher Scientific, Genentech
Consultant: Nestle Sciences, Danone Nutricia
Researcher: DBV, Siolta Therapeutics
Peck Ong, MD – Speaker
Advisor: Dermavant, Amgen
Researcher: Regeneron
Rima Rachid, MD - Speaker
Researcher: Novartis, Siolta Therapeutics
Consultant: Novartis
Russell Settipane, MD – Speaker, Moderator, Planner, Reviewer
Speaker: AbbVie, Amgen, AstraZeneca, BioCryst, GSK, Genentech, Grifols, Pharming, Regeneron, Sanofi, Takeda
Advisor: AbbVie, Pfizer, AstraZeneca, BioCryst, GSK, DBV, Kalvista, Pharming
Independent Contractor: AstraZeneca, BioCryst, GSK, Regeneron, DBV, Genentech, Takeda
Julie Wang, MD - Speaker
Royalties: UpToDate
Researcher: DBV, Siolta
Dana Wallace, MD – Speaker
Consultant: Genentech, ARS, Bryn, Grifols
The following have no relevant financial relationships with ineligible companies:
Sam Bahna, MD - Speaker
Joseph Bellanti, MD – Speaker
Peter Capucilli, MD – Speaker
William Corrao, MD – Moderator, Planner
Ginny Loiselle - Coordinator
Katelyn Loiselle, BSN, RN – Planner
Emily McGowan, MD - Speaker
Robert Settipane, MD – Planner, Moderator
Marcus Shaker, MD - Speaker
Available Credit
- 16.25 AMA PRA Category 1 Credit™
- 16.25 Attendance
- 16.25 CBRN